Gainers
- TriSalus Life Sciences (NASDAQ:TLSI) stock moved upwards by 38.3% to $8.23 during Thursday's regular session. The market value of their outstanding shares is at $216.5 million.
- Immix Biopharma (NASDAQ:IMMX) shares rose 36.11% to $5.68. The company's market cap stands at $112.7 million.
- Codexis (NASDAQ:CDXS) stock moved upwards by 32.1% to $2.76. The company's market cap stands at $192.8 million.
- Science 37 Hldgs (NASDAQ:SNCE) stock moved upwards by 26.69% to $5.18. The company's market cap stands at $30.9 million.
- Shattuck Labs (NASDAQ:STTK) shares rose 25.9% to $6.12. The market value of their outstanding shares is at $259.9 million.
- RenovoRx (NASDAQ:RNXT) stock increased by 25.62% to $1.0. The company's market cap stands at $10.6 million.
Losers
- Reneo Pharmaceuticals (NASDAQ:RPHM) stock declined by 81.9% to $1.4 during Thursday's regular session. The market value of their outstanding shares is at $46.6 million.
- ThermoGenesis Holdings (NASDAQ:THMO) shares declined by 22.85% to $0.62. The company's market cap stands at $1.9 million.
- Apellis Pharmaceuticals (NASDAQ:APLS) shares fell 22.25% to $48.9. The company's market cap stands at $5.7 billion.
- NextCure (NASDAQ:NXTC) stock declined by 21.73% to $1.14. The market value of their outstanding shares is at $31.6 million.
- Motus GI Hldgs (NASDAQ:MOTS) shares decreased by 19.66% to $2.78. The market value of their outstanding shares is at $1.9 million.
- Intensity Therapeutics (NASDAQ:INTS) stock decreased by 16.91% to $8.21. The company's market cap stands at $112.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CDXSCodexis Inc
$2.74-0.72%
IMMXImmix Biopharma Inc
$3.200.63%
INTSIntensity Therapeutics Inc
$0.2367-7.50%
MOTSMotus GI Holdings Inc
$0.00020100.0%
NXTCNextCure Inc
$12.001.78%
RNXTRenovoRx Inc
$1.15-3.78%
STTKShattuck Labs Inc
$1.82-5.21%
THMOThermoGenesis Holdings Inc
$0.00010-100.0%
TLSITriSalus Life Sciences Inc
$5.03-2.14%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.